neuroClues
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
neuroClues - overview
Established
2020
Location
Louvain-la-Neuve, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Founded in 2020 by co-founders Pierre Daye, Pierre Pouget, and Antoine Pouppez and based in Louvain-la-Neuve, Belgium, P3Lab SRL, trading under the name NeuroClues, is a developer of a medical device that offers biomarkers that enable the identification of neurological disorders such as multiple sclerosis, Parkinson's disease, and Alzheimer's disease. NeuroClues is a portable eye-tracking device specifically designed for the clinical setting. The user-friendly tool allows neurologists to assess a patient's eye movements. This data analysis enables personalised treatment strategies and improves patient outcomes.
The technology allows for earlier diagnosis of diseases like Parkinson's, even before symptoms appear. The company will use the April 2024c funding to aid with the product development and market extension of neuroClues, which is presently being incubated at the Paris Brain Institute's innovation acceleration center in Europe and North America.
Current Investors
Invest.BW, European Innovation Council, White Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Web Applications, Analytics & Performance Software
Website
www.neuroclues.com/
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.